Search Results for 'amyris'

Amyris teams with Portuguese universities to boost AI and use of wastes

Amyris teams with Portuguese universities to boost AI and use of wastes

June 13, 2018 |

In California, Amyris announced that it has executed an agreement for a significant project consortium in Europe with the Universidade Católica Portuguesa (UCP) Porto Campus and AICEP Portugal Global (AICEP). UCP is a university system, including the leading biotech school in Portugal, and operates 15 research centers. AICEP is an independent public entity of the […]

Read More

BioDisruption: The Digest’s 2018 Multi-Slide Guide to Amyris

BioDisruption: The Digest’s 2018 Multi-Slide Guide to Amyris

May 28, 2018 |

For many people, a key question in the advanced bioeconomy is: “what is Amyris becoming, and when, and where and how?” Becoming a global leader in the health and beauty market, and self-funding operations in 2018 with at least $10 million in EBITDA this year — those are the answers appearing out of Emeryville now. […]

Read More

Going Our Way: The Digest’s 2018 Multi-Slide Guide to Amyris

Going Our Way: The Digest’s 2018 Multi-Slide Guide to Amyris

April 23, 2018 |

For many people, the key question is — what is Amyris becoming, and when, and where and how? We reported on Amyris’ progress most recently in “The New Colossus aims to unlock its Golden Door” and in Two Up: Amyris, Queensland gamble on farnesene for SE Asia. Meanwhile, Amyris’ Jim Iacoponi gave this illuminating overview […]

Read More

LanzaTech, Novozymes, Amyris, DSM, Enerkem, POET, BASF, Genomatica and Braskem Hot 50 voting lead as voting nears final week

LanzaTech, Novozymes, Amyris, DSM, Enerkem, POET, BASF, Genomatica and Braskem Hot 50 voting lead as voting nears final week

January 25, 2018 |

Enerkem bolted into the #2 position and Braskem reached the top 5 in the 50 Hottest Companies in the Advanced Bioeconomy ballot, as subscriber balloting began to near the February 2nd conclusion for the 2018 poll. Overall, LanzaTech remains in the lead, followed by Enerkem, Amyris, Novozymes, Braskem, BASF, DSM, Genomatica, Renewable Energy Group and Poet-DSM. The […]

Read More

Amyris wins two grants for about $25 million

Amyris wins two grants for about $25 million

January 18, 2018 |

In California, Amyris announced two grants that have been awarded, valued in aggregate at approximately $25 million, to accelerate innovation and enable the company to further extend its leadership position in the industrial biotechnology sector. The first grant is in Europe and focused on furthering the company’s current artificial intelligence (AI) and Informatics platform at […]

Read More

LanzaTech, Novozymes, Amyris, DSM, Enerkem, POET, BASF, Genomatica and Braskem take early Hot 50 voting lead

LanzaTech, Novozymes, Amyris, DSM, Enerkem, POET, BASF, Genomatica and Braskem take early Hot 50 voting lead

January 3, 2018 |

LanzaTech, Novozymes, Amyris, DSM, Enerkem, POET, BASF, Genomatica and Braskem have taken the lead in early voting in the 50 Hottest Companies in the Advanced Bioeconomy ballot. The Digest released the early-voting totals from Subscriber Voting — which do not yet include Invited International Selector votes. This week’s summary includes photo and other bonus votes which are just […]

Read More

LanzaTech, Novozymes, Amyris, DSM, Enerkem, POET, BASF, Genomatica and Avantium among early Hot 50 voting leaders

LanzaTech, Novozymes, Amyris, DSM, Enerkem, POET, BASF, Genomatica and Avantium among early Hot 50 voting leaders

December 5, 2017 |

In Florida, LanzaTech, Novozymes, Amyris, DSM, Enerkem, POET, BASF, Genomatica and Avantium have taken the lead in early voting in the 50 Hottest Companies in the Advanced Bioeconomy ballot. The Digest released the early-voting totals from Subscriber Voting — which do not yet include Invited International Selector votes. This week’s summary includes phioto and other bonus votes which […]

Read More

Amyris’ Sweet-‘N-High: Biotech pioneer sells farnesene plant to DSM, focuses on next-gen sweetener

Amyris’ Sweet-‘N-High: Biotech pioneer sells farnesene plant to DSM, focuses on next-gen sweetener

November 20, 2017 |

The nine month and Q3 2017 results are in for Amyris, and there’s reason for the long-suffering shareholder to take some near-Christmas cheer. YTD revenue is up more than 1/3 and product revenue has more than doubled. Guidance for year-end revenues was upped. The company has found a new deep-pocketed champion in DSM. But there […]

Read More

Making Renewables Mainstream: The Digest’s 2017 Multi-Slide Guide to Amyris

Making Renewables Mainstream: The Digest’s 2017 Multi-Slide Guide to Amyris

October 26, 2017 |

  We reported on Amyris’ progress recently in “The New Colossus aims to unlock its Golden Door” and in Two Up: Amyris, Queensland gamble on farnesene for SE Asia. Meanwhile, Amyris President of R&D Joel Cherry presented these illuminating slides on the company’s progress at ABLC 2017 in San Francisco.

Read More

Amyris announces second product development tie up with Royal DSM

Amyris announces second product development tie up with Royal DSM

September 26, 2017 |

In California, Amyris, Inc. announced that it has entered into a product development and production agreement for Vitamin A with Koninklijke DSM N.V. This marks the second such agreement between the two parties. DSM is partnering with Amyris to fund the development of the technology to produce Vitamin A on a cost-advantaged basis utilizing Amyris’s […]

Read More